Asthma, Aspirin-Induced
Asthma, Aspirin-Induced
Explore linked clinical trials. Standard reference: MESH:M05236461 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease | Asthma, Aspirin-Induced, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hypersensitivity, Immediate, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, asthma, bronchial disorder, drug allergy, immune system disorder, nasal cavity polyp, nasal disorder, otorhinolaryngologic disease, polyp, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-08-13 | NCT05575037 |